Recent reports have shown that EMT, which is characterized by the loss of epithelial markers such as E-cadherin and the induction of mesenchymal markers, including vimentin, N-cadherin, and fibronectin [42], plays a pivotal role in breast cancer progression [43,44,45]. Here, FN1 is linked to breast cancer.